Why Is This Important?

Acute myeloid leukemia (AML) is a cancer of the bone marrow and the blood that progresses rapidly without treatment. AML mostly affects cells that aren't fully developed, leaving these cells unable to carry out their normal functions.

Definition

Incidence rate of acute myeloid leukemia for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.

Data Sources

• SEER*Stat, National Center Institute
  (https://www.seer.cancer.gov/seerstat)
• Bridged-race population estimates, National Cancer Institute
  (https://seer.cancer.gov/popdata/)

How the Measure is Calculated

How Are We Doing?

During 2021, 271 New Jersey males and 252 females of all ages were diagnosed with acute myeloid leukemia.

What Is Being Done?

A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.nj.gov/health/ces/public/resources/occp.shtml]

Available Services

The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention. Cancer Epidemiology Services: [https://nj.gov/health/ces/] Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. [https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml] Office of Cancer Control and Prevention: [https://www.nj.gov/health/ces/public/resources/occp.shtml] NJ Cancer Education and Early Detection (NJCEED): [https://www.nj.gov/health/ces/public/resources/njceed.shtml] NJ Commission on Cancer Research: [https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml]